ZFAND6: A Potential Drug Target and Biomarker (G54469)

Target Name: ZFAND6

NCBI ID: G54469

ZFAND6

ZFAND6: A Potential Drug Target and Biomarker

ZFAND6, a gene encoding for a protein known as ZFAND6, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. ZFAND6 has unique structural features that give it a unique position in the biology of the human body, and its research has the potential to lead to new treatments and cures.

The ZFAND6 gene was first identified in 2018 using computational tools, and its function has since been extensively studied. ZFAND6 is a member of the Z-factor family of proteins, which are known for their role in regulating various cellular processes, including cell signaling, DNA replication, and inflammation. ZFAND6 is specifically involved in the regulation of cell adhesion, a critical process that helps maintain tissue structure and function.

One of the key features of ZFAND6 is its ability to interact with various proteins, including the T-cell receptor (TCR), a protein that plays a critical role in cell signaling and immune response. This interaction between ZFAND6 and TCR has been shown to promote the development of cancer cells, and may also contribute to the development of neurodegenerative disorders.

In addition to its role in cell signaling, ZFAND6 has also been shown to play a key role in the development and progression of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. For example, studies have shown that ZFAND6 is expressed in various types of cancer cells, and that its levels are often increased in these cells compared to healthy cells. This suggests that ZFAND6 may be a useful target for cancer treatments.

Another potential application of ZFAND6 is its potential as a biomarker for various diseases. The ZFAND6 protein has been shown to be expressed in a variety of tissues and cells, including blood cells, lymphocytes, and brain cells. This makes it a potential candidate for use as a biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

In addition to its potential as a drug target and biomarker, ZFAND6 also has unique structural features that give it a unique position in the biology of the human body. The ZFAND6 protein has a unique propensity to form aggregates, which can lead to its inability to function properly. This unique property has implications for the development of diseases where the body's own immune system becomes abnormally active, such as cancer and neurodegenerative disorders.

In conclusion, ZFAND6 is a gene encoding for a protein with unique structural features that give it a unique position in the biology of the human body. ZFAND6 has been shown to be involved in the regulation of cell adhesion and has been linked to the development and progression of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its potential as a drug target and biomarker has significant implications for the development of new treatments and cures. Further research is needed to fully understand the role of ZFAND6 in the human body and its potential as a drug target and biomarker.

Protein Name: Zinc Finger AN1-type Containing 6

Functions: Involved in regulation of TNF-alpha induced NF-kappa-B activation and apoptosis. Involved in modulation of 'Lys-48'-linked polyubiquitination status of TRAF2 and decreases association of TRAF2 with RIPK1. Required for PTS1 target sequence-dependent protein import into peroxisomes and PEX5 stability; may cooperate with PEX6. In vitro involved in PEX5 export from the cytosol to peroxisomes (By similarity)

The "ZFAND6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZFAND6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets